Aurora Cannabis stock (ACB) has been on a tear in 2019, rising 58.5% since the start of the year. It hasn’t been a straight shot upward for the Canadian cannabis company, but Aurora’s acquisition of Whistler Medical Marijuana drew cheers in January, as did its earnings in February. This has all come amid general enthusiasm for pot stocks on Wall Street and among other consumer products companies.